A Trial to Test if TEV-56286 is Effective for Treatment of Participants With Multiple System Atrophy

ישראלמגייס משתתפיםPHASE2

מצבים רפואיים

Multiple System Atrophy

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Teva Investigational Site 15554, La Jolla, California, United States

  • Teva Investigational Site 15545, Los Angeles, California, United States

  • Teva Investigational Site 15547, Washington D.C., District of Columbia, United States

  • Teva Investigational Site 15544, Boca Raton, Florida, United States

  • Teva Investigational Site 15555, Tampa, Florida, United States

  • Teva Investigational Site 15550, Chicago, Illinois, United States

  • Teva Investigational Site 15546, Kansas City, Kansas, United States

  • Teva Investigational Site 15736, Boston, Massachusetts, United States

  • Teva Investigational Site 15870, Farmington Hills, Michigan, United States

  • Teva Investigational Site 15552, Rochester, Minnesota, United States

  • Teva Investigational Site 15549, New York, New York, United States

  • Teva Investigational Site 15551, New York, New York, United States

  • Teva Investigational Site 15553, Durham, North Carolina, United States

  • Teva Investigational Site 15735, Hershey, Pennsylvania, United States

  • Teva Investigational Site 15548, Pittsburgh, Pennsylvania, United States

  • Teva Investigational Site 15874, Nashville, Tennessee, United States

  • Teva Investigational Site 15869, Georgetown, Texas, United States

  • Teva Investigational Site 15873, Alexandria, Virginia, United States

  • Teva Investigational Site 15543, Spokane, Washington, United States

  • Teva Investigational Site 35290, Bordeaux, France

  • Teva Investigational Site 35300, Caen, France

  • Teva Investigational Site 35289, Marseille, France

  • Teva Investigational Site 35291, Paris, France

  • Teva Investigational Site 35292, Toulouse, France

  • Teva Investigational Site 32823, Beelitz, Germany

  • Teva Investigational Site 32818, Dresden, Germany

  • Teva Investigational Site 32822, Düsseldorf, Germany

  • Teva Investigational Site 32825, Kassel, Germany

  • Teva Investigational Site 32826, Leipzig, Germany

  • Teva Investigational Site 32824, Marburg, Germany

  • Teva Investigational Site 32820, München, Germany

  • Teva Investigational Site 32819, Münster, Germany

  • Teva Investigational Site 32821, Ulm, Germany

  • Teva Investigational Site 80203, Haifa, Israel

  • Teva Investigational Site 80215, Jerusalem, Israel

  • Teva Investigational Site 80204, Tel Aviv, Israel

  • Teva Investigational Site 30299, Bologna, Italy

  • Teva Investigational Site 30297, Catania, Italy

  • Teva Investigational Site 30298, Milan, Italy

  • Teva Investigational Site 30294, Padova, Italy

  • Teva Investigational Site 30296, Roma, Italy

  • Teva Investigational Site 30295, Salerno, Italy

  • Teva Investigational Site 84140, Chiba, Japan

  • Teva Investigational Site 84139, Fuchū, Japan

  • Teva Investigational Site 84136, Gifu, Japan

  • Teva Investigational Site 84137, Niigata, Japan

  • Teva Investigational Site 84138, Sagamihara, Japan

  • Teva Investigational Site 84141, Sanda-shi, Japan

  • Teva Investigational Site 84135, Sendai, Japan

  • Teva Investigational Site 31328, Barakaldo, Spain

  • Teva Investigational Site 31323, Barcelona, Spain

  • Teva Investigational Site 31321, Barcelona, Spain

  • Teva Investigational Site 31324, Barcelona, Spain

  • Teva Investigational Site 31329, Elche, Spain

  • Teva Investigational Site 31327, Madrid, Spain

  • Teva Investigational Site 31330, Madrid, Spain

  • Teva Investigational Site 31331, Madrid, Spain

  • Teva Investigational Site 31320, Pamplona, Spain

  • Teva Investigational Site 31322, Seville, Spain

  • Teva Investigational Site 31319, Valencia, Spain

מובילי המחקר
  • Tev Medical Expert, Study Director

    Study Director

    Teva Branded Pharmaceutical Products R&D LLC